{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T05:04:21Z","timestamp":1735448661871,"version":"3.32.0"},"reference-count":28,"publisher":"Medical Association of Nippon Medical School","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2024,12,25]]},"DOI":"10.1272\/jnms.jnms.2024_91-613","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T22:15:41Z","timestamp":1735251341000},"page":"534-540","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Screening Data for Liver Fibrosis in Psoriasis Patients Treated with Biologics"],"prefix":"10.1272","volume":"91","author":[{"given":"Susumu","family":"Ichiyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeko","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeang","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Atsukawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Iwakiri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Hagino","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Hoashi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehisa","family":"Saeki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kanda N, Hoashi T, Saeki H. Nutrition and psoriasis. Int J Mol Sci. 2020 Jul;21 (15):5405.","DOI":"10.3390\/ijms21155405"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kanda N, Hoashi T, Saeki H. The defect in regulatory T cells in psoriasis and therapeutic approaches. J Clin Med. 2021 Aug;10 (17):3880.","DOI":"10.3390\/jcm10173880"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shibata Y, Fukuda T, Nobeyama Y, Asahina A. Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: chest CT imaging for screening purposes. J Dermatol. 2022 Dec;49 (12):1263-7.","DOI":"10.1111\/1346-8138.16564"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kamiya K, Oiso N, Kawada A, Ohtsuki M. Epidemiological survey of the psoriasis patients in the Japanese Society for Psoriasis Research from 2013 to 2018. J Dermatol. 2021 Jun;48 (6):864-75.","DOI":"10.1111\/1346-8138.15803"},{"key":"5","unstructured":"5. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Dec;78 (6):1966-86."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Neagoe CD, Farmazon AS, Amzolini AM, et al. The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients. Rom J Morphol Embryol. 2020 Apr-Jun;61 (2):503-11.","DOI":"10.47162\/RJME.61.2.20"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Prussick RB, Miele L. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden? Br J Dermatol. 2018 Jul;179 (1):16-29.","DOI":"10.1111\/bjd.16239"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009 Oct;51 (4):758-64.","DOI":"10.1016\/j.jhep.2009.04.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Madanagobalane S, Anandan S. The increased prevalence of nonalcoholic liver disease in psoriatic patients: a study from South India. Australas J Dermatol. 2012 Aug;53 (3):190-7.","DOI":"10.1111\/j.1440-0960.2012.00905.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Abedini R, Salehi M, Lajevardi V, Beygi S. Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clin Exp Dermatol. 2015 Oct;40 (7):722-7.","DOI":"10.1111\/ced.12672"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Saeki H, Mabuchi T, Asahina A, et al. English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). J Dermatol. 2023 Feb;50 (2):e41-68.","DOI":"10.1111\/1346-8138.16691"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006 Jun;43 (6):1317-25.","DOI":"10.1002\/hep.21178"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Neagoe CD, Farmazon AS, Amzolini AM, et al. The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients. Rom J Morphol Embryol. 2020 Apr-Jun;61 (2):503-11.","DOI":"10.47162\/RJME.61.2.20"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Macia-Villa C, Morell-Hita JL, Revenga-Martinez M, Diaz-Miguel Perez C. HLA-Cw6 allele and biologic therapy are protective factors against liver fibrosis in psoriatic arthritis patients. Clin Exp Rheumatol. 2023 May;41 (5):1179-82.","DOI":"10.55563\/clinexprheumatol\/anuuqb"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006 Aug;54 (8):2665-73.","DOI":"10.1002\/art.21972"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fujita H, Terui T, Hayama K, et al. Japanese guideline for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol. 2018 Nov;45 (11):1235-70.","DOI":"10.1111\/1346-8138.14523"},{"key":"17","unstructured":"17. Akuta N. [Non-invasive test for the diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease, and follow-up strategy]. Clinical Gastroenterology. 2021 Jul;36 (7):755-61. Japanese."},{"key":"18","unstructured":"18. Sumida Y, Ishiba H, Fujii H, et al. [Diagnosis and therapy for nonalcoholic fatty liver disease (NAFLD)]. Kanzo Clinical Update. 2022 Oct;7 (2):171-8. Japanese."},{"key":"19","unstructured":"19. Nakajima A, Ogawa Y, Imajo K, Yoneda M, Saito S. [How to identify the high risk NAFLD patients]. Kanzo Clinical Update. 2019 Oct;5 (2):131-5. Japanese."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. McPherson S, Hardy T, Dufour JF, et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017 May;112 (5):740-51.","DOI":"10.1038\/ajg.2016.453"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Tarnsplant. 2013 Mar;48 (3):452-8.","DOI":"10.1038\/bmt.2012.244"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol. 2022 Apr;76 (4):959-74.","DOI":"10.1007\/978-3-031-08552-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Seitz M, Reichenbach S, Moller B, Zwanhlen M, Villiger PM, Dufour JF. Hepatoprotective effect of tumor necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study. Ann Rheum Dis. 2010 Jun;69 (6):1148-50.","DOI":"10.1136\/ard.2009.116194"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Takamura S, Teraki Y, Katayama E, et al. Effects of interkeukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: directed acyclic graphs. Clin Mol Hepatol. 2022 Apr;28 (2):269-72.","DOI":"10.3350\/cmh.2022.0040"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Takeshima R, Kamata M, Suzuki S, et al. Interleukin-23 inhibitors decrease Fibrosis-4 index in psoriasis patients with elevated Fibrosis-4 index but not interleukin-17 inhibitors. J Dermatol. 2024 Sep;51 (9):1216-24. doi: 10.1111\/1346-8138.17277","DOI":"10.1111\/1346-8138.17277"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring system can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010 Sep;59 (9):1265-9.","DOI":"10.1136\/gut.2010.216077"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012 Jan;12:2.","DOI":"10.1186\/1471-230X-12-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ishiba H, Sumida Y, Tanaka S, et al. The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study. J Gastroenterol. 2018 Nov;53 (11):1216-24.","DOI":"10.1007\/s00535-018-1474-y"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/6\/91_JNMS.2024_91-613\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T05:05:36Z","timestamp":1735362336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/91\/6\/91_JNMS.2024_91-613\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,25]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.jnms.2024_91-613","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"type":"print","value":"1345-4676"},{"type":"electronic","value":"1347-3409"}],"subject":[],"published":{"date-parts":[[2024,12,25]]},"article-number":"JNMS.2024_91-613"}}